Health Strategies

1288. Deputy Brendan Smith asked the Minister for Health further to Parliamentary Question No. 1677 of 18 March 2026, the progress to date in finalising a strategy; when same will be published; and if she will make a statement on the matter. [30940/26]

2820. Deputy Pat Buckley asked the Minister for Health to provide an update on the current situation with the MCAP scheme; if a chairperson has been put in place yet; and if she will make a statement on the matter. [24398/26]

3056. Deputy Mark Wall asked the Minister for Health whether the National Dementia Strategy will be updated; the status of the National Dementia Strategy in relation to the Model of Care for Dementia; whether a full-term review is intended to be published following the 2018 Mid-Term Review; whether the National Dementia Strategy Monitoring Group are presently active; and if she will make a stateme…

3238. Deputy Pádraig Rice asked the Minister for Health the status of the Review of Access to Cannabis for Medical Use, following the appointment of a chair; if the Review Group has held its first meeting [26569/26]

3288. Deputy Ken O'Flynn asked the Minister for Health the national policy targets or benchmarks in place for the time taken from notification of a meningococcal disease case to public health intervention, including contact identification and prophylaxis; and if she will make a statement on the matter. [26763/26]

3289. Deputy Ken O'Flynn asked the Minister for Health the policy basis, circulation scope, and frequency of clinical alerts issued by the HSE National Health Protection Office in response to international infectious disease outbreaks, including the recent meningococcal outbreak in the United Kingdom; and if she will make a statement on the matter. [26764/26]

3293. Deputy Ken O'Flynn asked the Minister for Health whether a formal risk assessment has been conducted in response to the recent meningococcal outbreak in the United Kingdom; whether defined epidemiological or operational thresholds exist to trigger enhanced public health measures or communications; and if she will make a statement on the matter. [26768/26]

513. Deputy Pádraig Rice asked the Minister for Health if there are plans to roll out a school-based oral health promotion initiative to all primary schools (details supplied); if her Department is carrying out any work in this regard; and if she will make a statement on the matter. [23519/26]

514. Deputy Pádraig Rice asked the Minister for Health if she will meet with an organisation regarding their oral health promotion initiatives (details supplied); and if she will make a statement on the matter. [23520/26]

322. Deputy Jen Cummins asked the Minister for Health the way in which the commitments in the National Rare Disease Strategy 2025–2030 and the 2026 IPHA Framework Agreement particularly the 180-day decision timeline is being applied to the case to prevent further delay in addressing the need of people with Friedreich’s ataxia. [22550/26]

368. Deputy Máire Devine asked the Minister for Health how the commitments in the National Rare Disease Strategy 2025-2030 and the 2026 IPHA Framework Agreement, particularly the 180-day decision timeline, are being applied to the case of patients with Friedrich's Ataxia to prevent further delay in addressing a clear unmet need for treatment and reimbursement. [22736/26]

439. Deputy Marie Sherlock asked the Minister for Health the status of the clinical lead to support the implementation of the National Model of Care for Epilepsy; whether clinical lead hours continue to be allocated; and if she will make a statement on the matter. [23064/26]

935. Deputy Louise O'Reilly asked the Minister for Health when the new national drugs strategy will be published; and if she will make a statement on the matter. [21892/26]

1652. Deputy Conor Sheehan asked the Minister for Health further to the publication of the draft National Drugs Strategy 2026-2029, to outline the proposed governance, funding flows and accountability arrangements for the regional structures within the HSE Health Regions; whether Local Drug and Alcohol Task Forces will retain independent governance and decision-making authority over locally delive…

1653. Deputy Conor Sheehan asked the Minister for Health the way in which funding will be allocated within the proposed regional structures under the draft National Drugs Strategy 2026-2029; whether deprivation, social exclusion and patterns of entrenched drug-related harm will be formally weighted alongside population in determining resource allocation; and if she will publish the criteria to be …

1654. Deputy Conor Sheehan asked the Minister for Health the specific measures which will be put in place to protect the independent, community-led role of Local Drug and Alcohol Task Forces under the proposed regional governance arrangements in the draft National Drugs Strategy 2026-2029; and if she will make a statement on the matter. [18238/26]

1655. Deputy Conor Sheehan asked the Minister for Health whether, under the proposed regional structures in the draft National Drugs Strategy 2026-2029, all public funding for community-based drug services, including Local Drug and Alcohol Task Forces, will be pooled at HSE Health Region level; what safeguards will be put in place to prevent dilution of funding to areas of high deprivation; and if…

1663. Deputy James Geoghegan asked the Minister for Health the position regarding the publication of the AI for Care strategy; and if she will make a statement on the matter. [18278/26]

1668. Deputy Mark Ward asked the Minister for Health the specific measures which he will put in place to protect the independent, community-led role of Local Drug and Alcohol Task Forces under the proposed regional governance arrangements in the draft National Drugs Strategy 2026-2029; and if she will make a statement on the matter. [18290/26]

1677. Deputy Brendan Smith asked the Minister for Health the progress to date on developing and resourcing a national sepsis strategy; and if she will make a statement on the matter. [18349/26]

1682. Deputy John Lahart asked the Minister for Health further to the publication of the draft National Drugs Strategy 2026–2029, to outline the proposed governance, funding flows and accountability arrangements for the regional structures within the HSE health regions; whether local drug and alcohol task forces will retain independent governance and decision-making authority over locally delivere…

1683. Deputy John Lahart asked the Minister for Health the way funding will be allocated within the proposed regional structures under the draft National Drugs Strategy 2026–2029; whether deprivation, social exclusion and patterns of entrenched drug-related harm will be formally weighted alongside population in determining resource allocation; and if she will publish the criteria to be used by HSE…

1684. Deputy John Lahart asked the Minister for Health the specific measures that will be put in place to protect the independent, community-led role of local drug and alcohol task forces under the proposed regional governance arrangements in the draft National Drugs Strategy 2026–2029; and if she will make a statement on the matter. [18389/26]

1685. Deputy John Lahart asked the Minister for Health whether, under the proposed regional structures in the draft National Drugs Strategy 2026–2029, all public funding for community-based drug services, including local drug and alcohol task forces, will be pooled at HSE health region level; the safeguards that will be put in place to prevent dilution of funding to areas of high deprivation; and …

1693. Deputy Pádraig Rice asked the Minister for Health further to the publication of the draft National Drugs Strategy 2026–2029, to outline the proposed governance, funding flows and accountability arrangements for the regional structures within the HSE health regions; if the local drug and alcohol task forces will retain independent governance and decision-making authority over locally delivere…